» Articles » PMID: 25197370

Clinicopathological Characteristics of Four Cases of EBV Positive T-cell Lymphoproliferative Disorders of Childhood in China

Overview
Specialty Pathology
Date 2014 Sep 9
PMID 25197370
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A new category, "EBV positive T-cell lymphoproliferative disorders (LPD) of childhood", was proposed in the 2008 World Health Organization's (WHO) classifications of lymphoma. This series of lymphoproliferative disorders is rare. There are two major types of this series of disorders: systemic EBV positive T-cell LPD of childhood and hydroa vacciniforme-like lymphoma (HVLL). In this study, we describe the distinct features of four cases of EBV positive T-cell LPD of childhood in China. Two were systemic EBV positive T-cell LPD of childhood, one was HVLL and one was chronic active EBV (CAEBV). The main manifestations were lymphadenopathy, fever, hepatosplenomegaly and skin rashes. The structure of the lymph nodes in the patients ranged from preserved to partially or totally destroyed. Small- to medium-sized, atypical T cells had infiltrated the lymph nodes. In HVLL, the neoplastic cells had infiltrated the dermis and subcutaneous region surrounding sweat glands and nerves. All of the cases tested positive for CD8, other T cells, cytotoxic markers and EBV-encoded RNA (EBER) without CD56 expression. Molecular analysis was performed in three cases. All of the three analyses showed a TCRγ rearrangement and one case also had an IGH rearrangement. One of the patients with systemic EBV positive T-cell LPD of childhood experienced rapid evolved and died within five months of onset. CAEBV, systemic EBV-positive T-cell LPD of childhood and HVLL are distinct but overlapping diseases within the category of EBV-positive T-cell LPD of childhood. They constitute a continuous spectrum of EBV-infected associated disorders.

Citing Articles

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland.

Ai J, Xie Z Front Pediatr. 2018; 6:289.

PMID: 30356785 PMC: 6189562. DOI: 10.3389/fped.2018.00289.


Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.

Ali A, Al-Shraim M, Al-Hakami A, Jones I Open Virol J. 2016; 9:7-28.

PMID: 26862355 PMC: 4740969. DOI: 10.2174/1874357901509010007.


Clinical characteristics and prognostic factors of patients with mature T-cell lymphoid malignancies: a single-institution study of 225 cases.

Xue W, Sheng Y, Weng X, Zhu Y, Zhao Y, Xu P Front Med. 2015; 9(4):468-77.

PMID: 26559194 DOI: 10.1007/s11684-015-0419-6.

References
1.
Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S . Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol. 2004; 24(5):1165-74. View

2.
Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma D . Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000; 96(2):443-51. View

3.
Rodriguez-Pinilla S, Barrionuevo C, Garcia J, de los Angeles M, Pajares R, Casavilca S . Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases. Histopathology. 2011; 59(6):1183-93. DOI: 10.1111/j.1365-2559.2011.04047.x. View

4.
Lee H, Baek J, Lee J, Park S, Jeon I, Roh J . Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder. Am J Dermatopathol. 2012; 34(8):e119-24. DOI: 10.1097/DAD.0b013e3181c036de. View

5.
Cohen J, Jaffe E, Dale J, Pittaluga S, Heslop H, Rooney C . Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011; 117(22):5835-49. PMC: 3112034. DOI: 10.1182/blood-2010-11-316745. View